[ad_1]
FeelBetter, a machine learning-enabled medication-management platform targeted on polypharmacy, introduced it secured $5.9 million in funding led by Firstime Ventures and Shoni Well being Ventures.
Random Forest VC, The Group Ventures, and present FeelBetter investor Triventures additionally participated within the spherical.
The most recent spherical brings the corporate’s complete increase to $8 million.
WHAT IT DOES
FeelBetter focuses on the polypharmacy paradigm, the simultaneous use of a number of medication by one affected person for a number of situations. The corporate’s AI-enabled platform analyzes information on a affected person’s well being standing and medical historical past, pharmacology and scientific tips to look at the connections between the totally different sources to enhance a affected person’s medicine routine.
The corporate will use the funds to increase its attain and advance its platform.
“At a time when buyers are particularly selective concerning the forms of bets they’re taking, this spherical and vote of confidence from the world-class groups at Firstime Ventures, Shoni Well being Ventures, Random Forest VC, Triventures, and The Enterprise Group, in addition to angel buyers, validates the necessity for and potential of our pharmaco-clinical intelligence as an answer for the rising, world well being problem posed by suboptimal medicine administration,” Liat Primor, FeelBetter’s CEO and cofounder stated in a press release.
MARKET SNAPSHOT
Polypharmacy has been proven to have an effect on one’s health-related high quality of life negatively, is typically seen in older adults and ends in numerous hospital admissions.
Different corporations within the medicine administration house embody Arine, which gives information analytics instruments for medicine administration, and retail large Walmart, which bought digital medicine administration firm CareZone‘s tech platform, patents and mental property in 2020.
[ad_2]
Source_link